Targeting the EGF Receptor for Ovarian Cancer Therapy : Table 3

]>Targeting the EGF Receptor for Ovarian Cancer Therapy : Table 3

Table 3: Clinical trials combining the EGF receptor antagonists with other signaling pathway inhibitors.

American Society of Clinical Oncology (ASCO) 2009 Annual Meeting Proceedings

Phase I trial of bevacizumab everolimus panitumumab in refractory solid tumors [117]

Phase I trial of cetuximab and erlotinib in solid tumors [119]

Phase I trial of dasatinib cetuximab in advanced solid tumors [120]